Cargando…
Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related deaths worldwide. There are two main subtypes: small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC). NSCLC accounts for 85% of lung cancer diagnoses. Early lung cancer very often has no specific symptoms, and many patients present w...
Autores principales: | Russell, Éilis, Conroy, Melissa J., Barr, Martin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869885/ https://www.ncbi.nlm.nih.gov/pubmed/35203256 http://dx.doi.org/10.3390/cells11040605 |
Ejemplares similares
-
Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017) -
Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022) -
Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies
por: St-Pierre, Frederique, et al.
Publicado: (2021) -
Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022) -
Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection
por: Alrubayyi, Aljawharah, et al.
Publicado: (2020)